Accessible version Medical Technology Medtech valuations – a new era Industry Overview Unprecedented times in medtech valuation BSX PE roughly at its WAMGR when it likely beats it There is a high correlation with medtech PEs and revenue growth rate (Exhibit 1). BSX trading at 31x 2026 EPS is correlated to 10.5% revenue growth (closer to 10% assuming EPS upside). BSX's WAMGR is around 10% today and BSX tends to outperform its WAMGR. A 11-12% growth is correlated to a 33-36x PE multiple. If investors begin to ...